Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
4
×
detroit blog main
detroit top stories
drugs
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
4
×
san diego blog main
san diego top stories
4
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
4
×
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
indiana blog main
indiana top stories
national
biotech
cell therapy
deals
fda
gene therapy
ginkgo bioworks
spark therapeutics
startups
synthetic biology
#ash2018
What
fda
admits
ago
ahead
american
annual
approved
asco
ash
big
bio
biotechs
blood
borne
branded
cancer
cancers
choices
classes
combinator
commissioner
companies
conference
consumers
costly
counterweight
deeper
diego
dna
drug
drugs
dug
elevatebio
fingerprint
gathering
generic
genetic
going
graft
guide
Language
unset
Current search:
drugs
×
cancer
×
" san diego top stories "
×
" texas blog main "
×
roche
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More